Catherine Priest, PhD, VP of
Preclinical Development at Neurona, filed the first successful IND application for a human pluripotent stem cell - based therapeutic as a former Senior Director at Geron Corporation.
One need not look further than the drug in late - stage
preclinical development at the US National Institute of Neurological Disorders and Stroke (NINDS) in Bethesda, Maryland.
She graduated from Trinity with honors in chemistry and participated in a summer internship in Pharmacology and
Preclinical Development at Tularik Inc. (currently Amgen) in South San Francisco.
Then follow up persistently, counsels Kate Stuart, founder and director of
preclinical development at Symic Biomedical, a startup in the San Francisco Bay Area.
Not exact matches
Glenn Pierce, vice president of
preclinical development and U.S. medical affairs
at Bayer Healthcare, says, «We developed a recombinant DNA construct for this protein, and that revolutionized therapy.»
«The pace of
preclinical and early clinical
development for Zika vaccines is unprecedented,» said Barouch, corresponding author and director of the Center for Virology and Vaccine Research
at BIDMC.
Seres Therapeutics (MCRB) Presents New
Preclinical Data Supporting the
Development of Microbiome Therapeutics for Immuno - Oncology
at AACR
Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced that new
preclinical data supporting the
development of microbiome therapeutics for immuno - oncology (leveraging gut microbiota to impact tumor immunotherapy) 1 will be presented today by Sceneay et al in the late breaking poster session
at the 2018 American Association for Cancer Research Annual Meeting (AACR) in Chicago.
She is CEO of PsychoGenics Inc., a profitable
preclinical CNS service company, CEO of PGI Drug Discovery LLC, a company engaged in psychiatric drug discovery with three partnered Phase II clinical programs and Adjunct Associate Professor of Neuroscience
at Mount Sinai School of Medicine, Dr. Leahy has more than 25 years of experience in drug discovery, clinical develop and business
development for pharmaceutical and biotechnology companies, including extensive knowledge of technology assessment, licensing, mergers and acquisitions, and strategic planning.
Over the course of its
development, PNP has secured grants from the National Institutes of Health of approximately $ 10 million to support
preclinical research
at Southern Research Institute and UAB.
Proclara Biosciences Presents New
Preclinical Data Supporting
Development of GAIM - Based Therapies
at Society for Neuroscience Annual Meeting November 14, 2017
Proclara Biosciences Presents New
Preclinical Data Supporting the
Development of NPT189
at Alzheimer's Association International Conference (AAIC) 2017 July 18, 2017
Proclara Biosciences Presents
Preclinical Data Supporting the
Development of GAIM - Based Therapies for Peripheral Amyloidoses
at the 16th International Symposium on Amyloidosis March 28, 2018
Dr. Bolen will oversee all aspects of R&D
at Moderna, including discovery research,
preclinical and clinical
development, and clinical operations.
Proclara Biosciences Presents
Preclinical Data Supporting the
Development of GAIM - Based Therapies for Peripheral Amyloidoses
at the 16th International Symposium on Amyloidosis
«We are excited to support the
preclinical and clinical
development work with the PEC - Direct product candidate, given its potential to help the type 1 diabetes patients with the most urgent medical need, those
at high risk of life - threatening acute complications.
This led to the establishment of international collaborations aimed
at preclinical identification,
development and selection of HIV vaccine candidates, such as NeutNet, a worldwide consortium dedicated to the standardisation of HIV neutralisation assays, and the Humoral Immunity Platform of EUROPRISE.
Performs genome - wide profiling of vector integration sites as readout of cell growth
at clonal level, in basic research studies and technology
development, in
preclinical safety studies and in gene therapy treated patients.
Researchers
at the Sanford Consortium for Regenerative Medicine have broad scientific goals in basic and
preclinical research, as well as
preclinical development of discoveries.
He was introduced to radiopharmaceutical
development as a postdoctoral research associate and then as a staff scientist in the department of radiology
at Washington University School of Medicine, where he developed several
preclinical imaging agents to study brain tumors, atherosclerosis and Alzheimer's disease.
At Vets Plus, Dr. Ajay leads new product
development initiatives, overseeing all
preclinical and clinical trials and research.